RU95120168A - INDOLIN-2-SHE DERIVATIVES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION - Google Patents
INDOLIN-2-SHE DERIVATIVES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTIONInfo
- Publication number
- RU95120168A RU95120168A RU95120168/04A RU95120168A RU95120168A RU 95120168 A RU95120168 A RU 95120168A RU 95120168/04 A RU95120168/04 A RU 95120168/04A RU 95120168 A RU95120168 A RU 95120168A RU 95120168 A RU95120168 A RU 95120168A
- Authority
- RU
- Russia
- Prior art keywords
- group
- substituted
- unsubstituted
- lower alkyl
- alkyl group
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 claims 33
- 125000003118 aryl group Chemical group 0.000 claims 22
- 125000003545 alkoxy group Chemical group 0.000 claims 15
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 239000011780 sodium chloride Substances 0.000 claims 12
- 125000000623 heterocyclic group Chemical group 0.000 claims 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000003277 amino group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 125000002947 alkylene group Chemical group 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 5
- 125000002252 acyl group Chemical group 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- -1 2,2-diethoxyethyl group Chemical group 0.000 claims 3
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 3
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 125000004432 carbon atoms Chemical group C* 0.000 claims 2
- 125000002877 alkyl aryl group Chemical group 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
Claims (12)
где R1 представляет атом галогена, низшую алкильную, низшую алкокси, гидроксильную, нитро, трифторметильную, низшую алкилтио, ацильную, карбоксильную, меркапто или замещенную или незамещенную аминогруппу; R2 представляет атом водорода, замещенную или незамещенную низшую алкильную группу, замещенную или незамещенную низшую алкенильную группу, замещенную или незамещенную низшую алкинильную группу, замещенную или незамещенную низшую алкоксигруппу, замещенную или незамещенную ацильную группу, замещенную или незамещенную арильную группу или замещенную или незамещенную гетероциклическую группу; R3 представляет замещенную или незамещенную низшую алкильную группу, замещенную или незамещенную циклоалкильную группу, замещенную или незамещенную арильную группу или замещенную или незамещенную гетероциклическую группу; R4 представляет атом водорода, замещенную или незамещенную низшую алкильную группу, замещенную или незамещенную арильную группу, замещенную или незамещенную гетероциклическую группу, -OR5, -SR5 или -NR6R7, где R5, R6 и R7, которые могут быть одинаковыми или разными, каждый представляет атом водорода, замещенную или незамещенную низшую алкильную группу, замещенную или незамещенную циклоалкильную группу, замещенную или незамещенную арильную группу, замещенную или незамещенную гетероциклическую группу, низшую алкоксигруппу или замещенную или незамещенную аминогруппу; или R6 и R7 вместе образуют -(CH2)m- или -(CH2)lNR8(CH2)k, где k, l и m каждый представляет целое число от 1 до 8, и R8 представляет атом водорода или низшую алкильную группу; Х и У, которые могут быть одинаковыми или разными, каждый представляет -CH2-, -NH- или -O-; n представляет целое число от 0 до 4, или его соль.1. The compound represented by formula I
where R 1 represents a halogen atom, a lower alkyl, lower alkoxy, hydroxyl, nitro, trifluoromethyl, lower alkylthio, acyl, carboxyl, mercapto, or a substituted or unsubstituted amino group; R 2 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted lower alkenyl group, a substituted or unsubstituted lower alkynyl group, a substituted or unsubstituted lower alkoxy group, a substituted or unsubstituted acyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocyclic group ; R 3 represents a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic group; R 4 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic group, -OR 5 , -SR 5, or -NR 6 R 7 , where R 5 , R 6 and R 7 , which may be the same or different, each represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic group, a lower alkoxy group, or a substituted silt unsubstituted amino group; or R 6 and R 7 together form - (CH 2 ) m - or - (CH 2 ) l NR 8 (CH 2 ) k , where k, l and m each represents an integer from 1 to 8, and R 8 represents an atom hydrogen or lower alkyl group; X and Y, which may be the same or different, each represents -CH 2 -, -NH-, or -O-; n represents an integer from 0 to 4, or its salt.
где R1 0 и R1 1 каждый представляет замещенную или незамещенную низшую алкильную группу, или группу, представленную формулой IV,
где Z представляет замещенную или незамещенную низшую алкиленовую группу.7. The compound or its salt according to claim 5, characterized in that in the general formula, IR 2 represents a group represented by formula III
where R 1 0 and R 1 1 each represents a substituted or unsubstituted lower alkyl group, or a group represented by formula IV,
where Z represents a substituted or unsubstituted lower alkylene group.
где R1 представляет атом галогена, низшую алкильную, низшую алкокси, гидроксильную, нитро, трифторметильную, низшую алкилтио, ацильную, карбоксильную, меркапто или замещенную или незамещенную аминогруппу; R3 представляет замещенную или незамещенную низшую алкильную группу, замещенную или незамещенную циклоалкильную группу, замещенную или незамещенную арильную группу или замещенную или незамещенную гетероциклическую группу; n представляет целое число от 0 до 4; R9 представляет группу формулы III
где R1 0 и R1 1 каждый представляет замещенную или незамещенную низшую алкильную группу или группу формулы IV
где Z представляет замещенную или незамещенную низшую алкиленовую группу, или его соль.11. The compound represented by formula II
where R 1 represents a halogen atom, a lower alkyl, lower alkoxy, hydroxyl, nitro, trifluoromethyl, lower alkylthio, acyl, carboxyl, mercapto, or a substituted or unsubstituted amino group; R 3 represents a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic group; n represents an integer from 0 to 4; R 9 represents a group of formula III
where R 1 0 and R 1 1 each represents a substituted or unsubstituted lower alkyl group or a group of formula IV
where Z represents a substituted or unsubstituted lower alkylene group, or its salt.
где R1 представляет атом галогена, низшую алкильную, низшую алкокси, гидроксильную, нитро, трифторметильную, низшую алкилтио, ацильную, карбоксильную, меркапто или замещенную или незамещенную аминогруппу; R9 представляет группу формулы III
где R1 0 и R1 1 каждый представляет замещенную или незамещенную низшую алкильную группу, или группу формулы IV
где Z представляет замещенную или незамещенную низшую алкиленовую группу; n представляет целое число от 0 до 4; Rа представляет низшую алкильную группу или арильную группу, или его соль.12. The compound represented by formula V
where R 1 represents a halogen atom, a lower alkyl, lower alkoxy, hydroxyl, nitro, trifluoromethyl, lower alkylthio, acyl, carboxyl, mercapto, or a substituted or unsubstituted amino group; R 9 represents a group of formula III
where R 1 0 and R 1 1 each represents a substituted or unsubstituted lower alkyl group, or a group of formula IV
where Z represents a substituted or unsubstituted lower alkylene group; n represents an integer from 0 to 4; R a represents a lower alkyl group or aryl group, or a salt thereof.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6729793 | 1993-02-17 | ||
JP67297/1993 | 1993-02-17 | ||
JP167262/1993 | 1993-05-31 | ||
JP16726293 | 1993-05-31 | ||
PCT/JP1994/000235 WO1994019322A1 (en) | 1993-02-17 | 1994-02-17 | Indolin-2-one derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95120168A true RU95120168A (en) | 1997-09-27 |
RU2128170C1 RU2128170C1 (en) | 1999-03-27 |
Family
ID=26408486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95120168A RU2128170C1 (en) | 1993-02-17 | 1994-02-17 | Derivatives of indoline-2-one and intermediate compounds for their synthesis |
Country Status (19)
Country | Link |
---|---|
US (5) | US5952511A (en) |
EP (1) | EP0685463B1 (en) |
JP (1) | JP3419539B2 (en) |
KR (1) | KR100226310B1 (en) |
CN (1) | CN1046268C (en) |
AT (1) | ATE217864T1 (en) |
AU (1) | AU6044894A (en) |
CA (1) | CA2156287C (en) |
CZ (1) | CZ290504B6 (en) |
DE (1) | DE69430664T2 (en) |
ES (1) | ES2176236T3 (en) |
FI (1) | FI112652B (en) |
HU (1) | HUT74105A (en) |
MY (1) | MY128102A (en) |
NO (1) | NO305201B1 (en) |
PL (1) | PL176710B1 (en) |
RU (1) | RU2128170C1 (en) |
TW (1) | TW281669B (en) |
WO (1) | WO1994019322A1 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878728B1 (en) | 1999-06-11 | 2005-04-12 | Vertex Pharmaceutical Incorporated | Inhibitors of aspartyl protease |
US20040122000A1 (en) | 1981-01-07 | 2004-06-24 | Vertex Pharmaceuticals Incorporated. | Inhibitors of aspartyl protease |
US5783701A (en) | 1992-09-08 | 1998-07-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
IS2334B (en) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl protease inhibitor of a new class of sulfonamides |
DE69429584T2 (en) * | 1993-11-26 | 2002-08-08 | Tanabe Seiyaku Co | 2-OXOINDOLINE DERIVATIVES AS CHOLECYSTOKININ RECEPTOR ANTAGONISTS |
US6127372A (en) * | 1994-03-07 | 2000-10-03 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
US5691372A (en) * | 1995-04-19 | 1997-11-25 | Vertex Pharmaceuticals Incorporated | Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease |
US6004957A (en) * | 1995-06-07 | 1999-12-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
AU2233097A (en) * | 1996-03-11 | 1997-10-01 | Chugai Seiyaku Kabushiki Kaisha | Process for the preparation of optically active indole compounds |
AU3459497A (en) * | 1996-07-12 | 1998-02-09 | Chugai Seiyaku Kabushiki Kaisha | Cancer cell proliferation inhibitors |
US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
PT1086076E (en) | 1998-06-19 | 2005-05-31 | Vertex Pharma | SULFONAMIDE INHIBITORS OF ASPARTIL PROTEASE |
ATE285769T1 (en) * | 1998-12-04 | 2005-01-15 | Neurosearch As | USE OF ISATINE DERIVATIVES AS ION CHANNEL ACTIVATION AGENTS |
US6605623B1 (en) | 1998-12-18 | 2003-08-12 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
JP4058243B2 (en) | 1999-01-29 | 2008-03-05 | 中外製薬株式会社 | Cartilage formation promoter and indoline-2-one derivative |
DE60041763D1 (en) * | 1999-04-23 | 2009-04-23 | Vertex Pharma | INHIBITORS OF C-JUN N-TERMINAL KINASEN (JNK) |
US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
KR20020070285A (en) | 1999-11-23 | 2002-09-05 | 메틸진, 인크. | Inhibitors of histone deacetylase |
AU2001236058A1 (en) * | 2000-03-10 | 2001-09-17 | Chugai Seiyaku Kabushiki Kaisha | Preparations for chondrogenesis |
US7612065B2 (en) | 2000-04-21 | 2009-11-03 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-JUN N-terminal kinases (JNK) |
WO2001098269A2 (en) * | 2000-06-21 | 2001-12-27 | Bristol-Myers Squibb Pharma Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
US6638950B2 (en) | 2000-06-21 | 2003-10-28 | Bristol-Myers Squibb Pharma Company | Piperidine amides as modulators of chemokine receptor activity |
WO2004056769A2 (en) * | 2002-12-20 | 2004-07-08 | Ciba Specialty Chemicals Holding Inc. | Synthesis of amines and intermediates for the synthesis thereof |
CN1324009C (en) * | 2003-01-30 | 2007-07-04 | 普文英 | Pharmaceutical use of 1-N-methoxy-2-oxo-indole-3-acetamide |
US20080030974A1 (en) * | 2006-08-02 | 2008-02-07 | Abu-Ageel Nayef M | LED-Based Illumination System |
US20090050905A1 (en) * | 2007-08-20 | 2009-02-26 | Abu-Ageel Nayef M | Highly Efficient Light-Emitting Diode |
US20100202129A1 (en) * | 2009-01-21 | 2010-08-12 | Abu-Ageel Nayef M | Illumination system utilizing wavelength conversion materials and light recycling |
WO2011053542A1 (en) * | 2009-10-30 | 2011-05-05 | Merck Sharp & Dohme Corp. | Heterocycle amide t-type calcium channel antagonists |
CN102516153B (en) * | 2011-12-14 | 2014-03-12 | 南京工业大学 | 5-fluoroindole-2-one-3-carbamide compounds, preparation method thereof and application thereof |
PL3071206T3 (en) | 2013-11-22 | 2022-01-17 | CL BioSciences LLC | Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis |
KR102161674B1 (en) * | 2014-02-18 | 2020-10-05 | 주식회사 대웅제약 | Isatin derivatives and method for preparation thereof |
CN113456631B (en) * | 2021-08-06 | 2022-06-21 | 徐州医科大学 | Small molecule drug targeting ACSL1 and application thereof in treatment of endometrial cancer |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
JPS62234080A (en) | 1985-12-20 | 1987-10-14 | Kissei Pharmaceut Co Ltd | Indolin-2-one derivative |
JPS62228072A (en) | 1985-12-20 | 1987-10-06 | Kissei Pharmaceut Co Ltd | 3-aminoindolin-3-one derivative |
US4760083A (en) | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
JPS62270576A (en) | 1986-05-19 | 1987-11-24 | Kissei Pharmaceut Co Ltd | Isatin derivative |
JPS62156771A (en) * | 1986-12-19 | 1987-07-11 | Tokyo Shokai:Kk | Prescription processor |
JPS63156771A (en) | 1986-12-19 | 1988-06-29 | Kissei Pharmaceut Co Ltd | 3-aminoindolin-2-one derivative |
US4876259A (en) * | 1987-01-05 | 1989-10-24 | E. I. Du Pont De Nemours And Company | 3,3-disubstituted indolines |
JPH03503650A (en) * | 1988-04-05 | 1991-08-15 | アボツト・ラボラトリーズ | Tryptophan derivatives as CCK antagonists |
JP3356431B2 (en) * | 1990-08-31 | 2002-12-16 | ワーナー―ランバート・コンパニー | Pro-drug for CCK antagonist |
WO1992007830A2 (en) | 1990-10-29 | 1992-05-14 | Pfizer Inc. | Oxindole peptide antagonists |
CA2055094A1 (en) * | 1990-11-13 | 1992-05-14 | Mark G. Bock | Cholecystokinin antagonist |
JPH05104510A (en) * | 1991-10-18 | 1993-04-27 | Inax Corp | Applying method for mortar to base substance |
-
1994
- 1994-02-16 TW TW083101206A patent/TW281669B/zh active
- 1994-02-16 JP JP05654194A patent/JP3419539B2/en not_active Expired - Fee Related
- 1994-02-16 MY MYPI94000344A patent/MY128102A/en unknown
- 1994-02-17 ES ES94907058T patent/ES2176236T3/en not_active Expired - Lifetime
- 1994-02-17 HU HU9502415A patent/HUT74105A/en unknown
- 1994-02-17 AT AT94907058T patent/ATE217864T1/en not_active IP Right Cessation
- 1994-02-17 WO PCT/JP1994/000235 patent/WO1994019322A1/en active IP Right Grant
- 1994-02-17 PL PL94310168A patent/PL176710B1/en not_active IP Right Cessation
- 1994-02-17 RU RU95120168A patent/RU2128170C1/en not_active IP Right Cessation
- 1994-02-17 EP EP94907058A patent/EP0685463B1/en not_active Expired - Lifetime
- 1994-02-17 CA CA002156287A patent/CA2156287C/en not_active Expired - Fee Related
- 1994-02-17 KR KR1019950703395A patent/KR100226310B1/en not_active IP Right Cessation
- 1994-02-17 DE DE69430664T patent/DE69430664T2/en not_active Expired - Fee Related
- 1994-02-17 CZ CZ19952096A patent/CZ290504B6/en not_active IP Right Cessation
- 1994-02-17 AU AU60448/94A patent/AU6044894A/en not_active Abandoned
- 1994-02-17 CN CN94191205A patent/CN1046268C/en not_active Expired - Fee Related
-
1995
- 1995-08-16 FI FI953866A patent/FI112652B/en active
- 1995-08-17 NO NO953235A patent/NO305201B1/en unknown
-
1997
- 1997-11-03 US US08/963,547 patent/US5952511A/en not_active Expired - Fee Related
-
1998
- 1998-10-30 US US09/182,638 patent/US6031111A/en not_active Expired - Fee Related
- 1998-10-30 US US09/182,490 patent/US6207836B1/en not_active Expired - Fee Related
- 1998-10-30 US US09/182,463 patent/US6114536A/en not_active Expired - Fee Related
- 1998-10-30 US US09/182,491 patent/US6127544A/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95120168A (en) | INDOLIN-2-SHE DERIVATIVES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION | |
NO308739B1 (en) | Imidazole derivatives as well as medical composition and anti-HIV composition comprising the same | |
RU98100090A (en) | PYRROLA DERIVATIVES AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS | |
RU93005057A (en) | PHARMACEUTICAL COMPOUNDS, THYENOBENZODIAZEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION, PHARMOCOMPOSITION AND THEIR USE | |
EA200100983A1 (en) | DERIVATIVES 13-METHYLERITROMYCIN | |
SE8204181D0 (en) | SET TO MAKE BENSOTIAZEPINE DERIVATIVES | |
DE59207226D1 (en) | Pharmacologically active hydrazine derivatives and process for their preparation | |
RU96104262A (en) | Pyrazole derivatives | |
RU93004417A (en) | NEW ARYL CYCLOALKYL DERIVATIVES, METHODS FOR THEIR PRODUCTION AND USE | |
ATE277049T1 (en) | SUBSTITUTED AMINOALKYL COMPOUNDS | |
KR900007827A (en) | Tocopherol analogues with cardioprotective action | |
FI885083A0 (en) | FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA L-PROLINDERIVAT. | |
DE69434198D1 (en) | METHOD OF LOWERING THE SERUM SCHOLESTERIN MIRROR WITH 2,6-DIALKYL-4 SILYL-PHENOL DERIVATIVES | |
EA199900648A1 (en) | SUBSTITUTED DERIVATIVES (1,3-BIS (CYCLOHEXILMETHYL) -1,2,3,6-TETRAHYDRO-2,6-DIOXO-9N-PURIN-8-IL) PHENYL, THEIR RECEIVING AND THEIR APPLICATION IN THE TREATMENT OF THE INFLAMMATORY THEMES. | |
SE8406302L (en) | NEW AMINOGUANIDE DERIVATIVES AND A PROCEDURE FOR THEIR PREPARATION | |
DE69209092T2 (en) | AROMATIC ESTERS OF PHENYLENDIAL CANOATES AS INHIBITORS OF HUMAN NEUTROPHILIC ELASTASE | |
KR950704278A (en) | OXAZOLINONE DERIVATIVE HAVING INTRACELLULAR PHOSPHOLIPASE A₂INHIBITOR ACTIVITY With Intracellular Phospholipase A 2 Inhibitory Activity | |
ES552509A0 (en) | PROCEDURE FOR THE PREPARATION OF DYSIMETRIC HETERO-CYCLIC ESTERS OF 1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLIC ACIDS. | |
RU93005114A (en) | FOAM CONNECTIONS AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS | |
ES2066387T3 (en) | NEW (MET) ACRYLIC COMPOUNDS CARRIERS OF THE THIOCIANATE FUNCTION, ITS PREPARATION PROCEDURE AND ITS APPLICATION TO THE OBTAINING OF NEW POLYMERS. | |
RU99100377A (en) | NEW AROMATIC DERIVATIVES, FILLED WITH RIBOSE, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS A MEDICINE | |
AU3872685A (en) | 3-phenyl-2-propeneamine derivatives | |
YU152091A (en) | 3,3-BISTIOALKYL-2-PYRIDYLACRYLIC ACID FUNGICIDAL DERIVATIVES | |
ATE18195T1 (en) | DIOXYBENZOLE ETHER DERIVATIVES, MEDICINES CONTAINING THEM, PROCESSES FOR THEIR PREPARATION AND THEIR USE. | |
KR950703536A (en) | PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS |